Search results for "malaria"
Selected Filters:
ELPRO’s data logging solutions
Twist Bioscience and Kyowa Kirin partner for GPCR antibody discovery
Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin
IDBS launches Polar BioAnalysis
The launch extends the Polar BioPharma Lifecycle Management (BPLM) platform with best practices in preclinical drug qualification
Thermo Fisher Scientific completes FDA listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
Twist Bioscience and Biotia receive FDA EUA for hybridization-based NGS SARS-CoV-2 assay
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
Artel MVS as a Tool For Measuring Liquid Mixing Efficacy in Microplates
Artel MVS as a Tool For Measuring Liquid Mixing Efficacy in Microplates
Andrew+ Pipetting Robot for LC/LC-MS general liquid handling
The connected laboratory for LC and LC-MS Workflow Automation
Electronic pipettes and the connected lab
Domino/Device+ Catalog
Octet® R Series Systems
Investigating traditional and modern approaches to antimicrobial susceptibility testing
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
New data published from Women & Infants Hospital demonstrate utility of predictive immune modeling in ovarian cancer
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
Aptamer Group and Mologic partner to develop aptamer-based SARS-CoV-2 rapid antigen test
This partnership aims to offer an accelerated route to market rapid test technologies
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall